The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon

Thrombosis Research
Yvonne van LeeuwenFelix J M van der Meer

Abstract

Vitamin K antagonists of the coumarin type are widely used oral anticoagulants. We developed a transition algorithm for the maintenance dosages of three frequently used coumarins: warfarin, phenprocoumon and acenocoumarol. The study was conducted at the Leiden Anticoagulation Clinic. Patients were participants in a trial of which the main objective was to compare the quality of an oral anticoagulant therapy with phenprocoumon to warfarin. We included patients who initiated oral anticoagulant therapy and patients who were already using acenocoumarol. Patients were randomized to a treatment with warfarin or phenprocoumon. Patients who were randomized to warfarin switched to phenprocoumon at the end of follow-up. We analysed the switch from acenocoumarol to warfarin or phenprocoumon at the start of follow-up and the switch of warfarin to phenprocoumon at the end of follow-up and calculated the transition factors for stable anticoagulation between these three vitamin K antagonists. Fifty-eight patients switched from warfarin to phenprocoumon, 39 from acenocoumarol to phenprocoumon and 44 from acenocoumarol to warfarin. The maintenance dose of warfarin was 0.41 (95%CI 0.39-0.43) times the maintenance dose of phenprocoumon. The trans...Continue Reading

References

Jan 1, 1979·Clinical Pharmacokinetics·J G Kelly, K O'Malley
Aug 1, 1978·Journal of Pharmaceutical Sciences·P G Welling, W A Craig
Apr 25, 1970·Lancet·E A Loeliger, H C Hemker
Dec 12, 1996·The New England Journal of Medicine·J S Ginsberg
Jun 1, 1964·The American Journal of the Medical Sciences·T RODMANM E RESNICK
Mar 14, 2012·Journal of Thrombosis and Haemostasis : JTH·R M F van SchieUNKNOWN EU-PACT study group

❮ Previous
Next ❯

Citations

Jan 8, 2009·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·P G PieperA P Van Dijk
Oct 16, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Espen Bjerke
Aug 4, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Aurel Constant AllabiJean-Luc Gala
Jul 14, 2011·QJM : Monthly Journal of the Association of Physicians·F D Richard Hobbs, I Leach
Mar 20, 2012·Thrombosis Research·Ann-Helen KristoffersenSverre Sandberg
Apr 20, 2011·Congenital Heart Disease·Nina HakacovaKatarina Hanséus
Oct 4, 2011·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Vanita SuriRajesh Vijayvergiya
Jan 13, 2015·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Gonçalo CardosoMiguel Mendes
Dec 9, 2017·Frontiers in Pharmacology·Vanessa Gonzalez-CovarrubiasXavier Soberon
Mar 5, 2015·Journal of the American Heart Association·Daniel E SingerUNKNOWN ROCKET AF Investigators
Apr 3, 2021·BMJ Case Reports·Martijn R BrandsArvid Wa Kamps

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.